Review

Critical function of Siah2 in tumorigenesis

  • Received: 31 July 2017 Accepted: 21 September 2017 Published: 11 October 2017
  • The seven in absentia homolog (Siah) family proteins are components of E3 RING zinc finger ubiquitin ligase complexes that catalyze the ubiquitination of proteins. Siah proteins target their substrates for proteasomal degradation. Evidence is growing that Siah proteins are implicated in the progression of various cancer cells and play a critical role in angiogenesis and tumorigenesis, particularly through Ras, p53, estrogen, and hypoxia inducible factor (HIF)-mediated signaling pathways in response to DNA damage or hypoxia.

    Citation: Kazunobu Baba, Tadaaki Miyazaki. Critical function of Siah2 in tumorigenesis[J]. AIMS Molecular Science, 2017, 4(4): 415-423. doi: 10.3934/molsci.2017.4.415

    Related Papers:

    [1] Yi Jiang, Kristin M. Kurianski, Jane HyoJin Lee, Yanping Ma, Daniel Cicala, Glenn Ledder . Incorporating changeable attitudes toward vaccination into compartment models for infectious diseases. Mathematical Biosciences and Engineering, 2025, 22(2): 260-289. doi: 10.3934/mbe.2025011
    [2] Eunha Shim . Optimal strategies of social distancing and vaccination against seasonal influenza. Mathematical Biosciences and Engineering, 2013, 10(5&6): 1615-1634. doi: 10.3934/mbe.2013.10.1615
    [3] Alessia Andò, Dimitri Breda, Giulia Gava . How fast is the linear chain trick? A rigorous analysis in the context of behavioral epidemiology. Mathematical Biosciences and Engineering, 2020, 17(5): 5059-5084. doi: 10.3934/mbe.2020273
    [4] Jinliang Wang, Gang Huang, Yasuhiro Takeuchi, Shengqiang Liu . Sveir epidemiological model with varying infectivity and distributed delays. Mathematical Biosciences and Engineering, 2011, 8(3): 875-888. doi: 10.3934/mbe.2011.8.875
    [5] Thomas Torku, Abdul Khaliq, Fathalla Rihan . SEINN: A deep learning algorithm for the stochastic epidemic model. Mathematical Biosciences and Engineering, 2023, 20(9): 16330-16361. doi: 10.3934/mbe.2023729
    [6] Rama Seck, Diène Ngom, Benjamin Ivorra, Ángel M. Ramos . An optimal control model to design strategies for reducing the spread of the Ebola virus disease. Mathematical Biosciences and Engineering, 2022, 19(2): 1746-1774. doi: 10.3934/mbe.2022082
    [7] Suxia Zhang, Hongbin Guo, Robert Smith? . Dynamical analysis for a hepatitis B transmission model with immigration and infection age. Mathematical Biosciences and Engineering, 2018, 15(6): 1291-1313. doi: 10.3934/mbe.2018060
    [8] Antonella Lupica, Piero Manfredi, Vitaly Volpert, Annunziata Palumbo, Alberto d'Onofrio . Spatio-temporal games of voluntary vaccination in the absence of the infection: the interplay of local versus non-local information about vaccine adverse events. Mathematical Biosciences and Engineering, 2020, 17(2): 1090-1131. doi: 10.3934/mbe.2020058
    [9] Holly Gaff, Elsa Schaefer . Optimal control applied to vaccination and treatment strategies for various epidemiological models. Mathematical Biosciences and Engineering, 2009, 6(3): 469-492. doi: 10.3934/mbe.2009.6.469
    [10] Ayako Suzuki, Hiroshi Nishiura . Transmission dynamics of varicella before, during and after the COVID-19 pandemic in Japan: a modelling study. Mathematical Biosciences and Engineering, 2022, 19(6): 5998-6012. doi: 10.3934/mbe.2022280
  • The seven in absentia homolog (Siah) family proteins are components of E3 RING zinc finger ubiquitin ligase complexes that catalyze the ubiquitination of proteins. Siah proteins target their substrates for proteasomal degradation. Evidence is growing that Siah proteins are implicated in the progression of various cancer cells and play a critical role in angiogenesis and tumorigenesis, particularly through Ras, p53, estrogen, and hypoxia inducible factor (HIF)-mediated signaling pathways in response to DNA damage or hypoxia.


    1. Introduction and the main result

    Nowadays, mathematics is useful in many things, for example, physics, chemistry, biology, computer, medical, architecture, and so on (see e.g., [3, 7, 14]). Here we focus on biology. One of the important models in biology is the logistic equation ut=u(1-u). Some of biological models have the logistic term, e.g., the Fisher-KPP equation

    ut=Δu+u(1u).

    On the other hand, many mathematicians study a chemotaxis system lately, which describes a part of the life cycle of cellular slime molds with chemotaxis. After the pioneering work of Keller-Segel [8], a number of variations of the chemotaxis system are proposed and investigated (see e.g., [2, 4, 5]). Also, multi-species chemotaxis systems have been studied by e.g., [6, 15]. In this paper we focus on a twospecies chemotaxis system with logistic term which describes a situation in which multi populations react on a single chemoattractant.

    We consider the two-species chemotaxis system

    {ut=Δu(uχ1(w)w)+μ1u(1u),xΩ,t>0,vt=Δv(vχ2(w)w)+μ2v(1v),xΩ,t>0,wt=dΔw+h(u,v,w),xΩ,t>0,un=vn=wn=0,xΩ,t>0,u(x,0)=u0(x),v(x,0)=v0(x),w(x,0)=w0(x),xΩ, (1.1)

    where Ω is a bounded domain in RN (NN) with smooth boundary Ω and n denotes the unit outer normal vector of Ω. The initial data u0, v0 and w0 are assumed to be nonnegative functions. The unknown functions u(x, t) and v(x, t) represent the population densities of two species and w(x, t) shows the concentration of the substance at place x and time t.

    In mathematical view, global existence and behavior of solutions are fundamental theme. Recently, Negreanu-Tello [12, 13] built a technical way to prove global existence and asymptotic behavior of solutions to (1.1). In [13] they dealt with (1.1) when d=0, µi > 0 under the condition

    ˉww0;h(ˉu,ˉv,ˉw)0,

    where ˉu, ˉv satisfy some representations determined by ˉw. In [12] they studied (1.1) when 0 < d < 1, µi=0 under similar conditions as in [13] and

    χi+11dχ2i0(i=1,2). (1.2)

    They supposed in [12, 13] that the functions h, χi for i=1, 2 generalize of the prototypical case χi(w)=Ki(1+w)σi (Ki>0,σi1), h(u,v,w)=u+vw. These days, the restriction of 0≤d < 1 for global existence is completely removed and asymptotic stability of solutions to (1.1) is established for the first time under a smallness condition for the function χi generalizing of χi(w)=Ki(1+w)σi (Ki>0,σi>1) ([11]).

    The purpose of this paper is to improve a way in [11] for obtaining asymptotic stability of solutions to (1.1) under a more general and sharp smallness condition for the sensitivity function χi(w). We shall suppose throughout this paper that h, χi (i=1, 2) satisfy the following conditions:

    χiC1+ω([0,))L1(0,)(0<ω<1),χi>0(i=1,2), (1.3)
    hC1([0,)×[0,)×[0,)),h(0,0,0)0, (1.4)
    γ>0; hu(u,v,w)0,hv(u,v,w)0,hw(u,v,w)γ, (1.5)
    δ>0,M>0;|h(u,v,w)+δw|M(u+v+1), (1.6)
    ki>0;χi(w)h(0,0,w)ki(i=1,2). (1.7)

    We also assume that

    p>N; 2dχi(w)+((d1)p+(d1)2p2+4dp)[χi(w)]20(i=1,2). (1.8)

    The above conditions cover the prototypical example χi(w)=Ki(1+w)σi (Ki>0, σi>1), h(u,v,w)=u+vw. We assume that the initial data u0, v0, w0 satisfy

    0u0C(ˉΩ){0}, 0v0C(ˉΩ){0}, 0w0W1,q(Ω)(q>N). (1.9)

    The following result which is concerned with global existence and boundedness in (1.1) was established in [11].

    Theorem 1.1 ([11, Theorem 1.1]). Let d≥0, µi > 0 (i=1, 2). Assume that h, χi satisfy (1.3)-(1.8). Then for any u0, v0, w0 satisfying (1.9) for some q > N, there exists an exactly one pair (u, v, w) of nonnegative functions

    u,v,wC(ˉΩ×[0,))C2,1(ˉΩ×(0,))when d>0,u,v,wC([0,);W1,q(Ω))C1((0,);W1,q(Ω))when d=0,

    which satisfy (1.1). Moreover, the solution (u; v; w) is uniformly bounded, i.e., there exists a constant C1 > 0 such that

    u(t)L(Ω)+v(t)L(Ω)+w(t)L(Ω)C1forall t0.

    Since Theorem 1.1 guarantees that u, v and w exist globally and are bounded and nonnegative, it is possible to define nonnegative numbers α, β by

    α:=max(u,v,w)Ihu(u,v,w),β:=max(u,v,w)Ihv(u,v,w), (1.10)

    where I=(0, C1)3 and C1 is defined in Theorem 1.1.

    Now the main result reads as follows. The main theorem is concerned with asymptotic stability in (1.1).

    Theorem 1.2. Let d > 0, µi > 0 (i=1, 2). Under the conditions (1.3)-(1.9) and

    α>0,β>0,χ1(0)2<16μ1dγα2+β2+2αβ,χ2(0)2<16μ2dγα2+β2+2αβ, (1.11)

    the unique global solution (u, v, w) of (1.1) satisfies that there exist C > 0 and λ>0 such that

    u(t)1L(Ω)+v(t)1L(Ω)+w(t)˜wL(Ω)Ceλt(t>0),

    where ˜w0 such that h(1, 1, ˜w)=0.

    Remark 1.1. This result improves the previous result [11, Theorem 1.2]. Indeed, the condition (1.11) is sharper than“χi(0) are suitably small”assumed in [11]. Moreover, this result attains to show the convergence rate which cannot be given in [11].

    Remark 1.2. From (1.4)-(1.6) there exists ˜w0 such that h(1,1,˜w)=0. Indeed, if we choose ˉw3M/δ, then (1.6) yields that h(1,1,ˉw)3Mδˉw0. On the other hand, (1.4) and (1.5) imply that h(1, 1, 0)≥h(0, 0, 0)≥0. Hence, by the intermediate value theorem there exists ˜w0 such that h(1, 1, ˜w)=0.

    The strategy for the proof of Theorem 1.2 is to modify an argument in [10]. The key for this strategy is to construct the following energy estimate which was not given in [11]:

    ddtE(t)ε(Ω(u1)2+Ω(v1)2+Ω(w˜w)2)

    with some function E(t)≥0 and some ε>0. This strategy enables us to improve the conditions assumed in [11].


    2. Proof of the main result

    In this section we will establish asymptotic stability of solutions to (1.1). For the proof of Theorem 1.2, we shall prepare some elementary results.

    Lemma 2.1 ([1, Lemma 3.1]). Suppose that f : (1, ∞)→R is a uniformly continuous nonnegative function satisfying 1f(t)dt<. Then f(t)0 as t.

    Lemma 2.2. Let a1,a2,a3,a4,a5R. Suppose that

    a1>0,a3>0,a5a224a1a244a3>0. (2.1)

    Then

    a1x2+a2xz+a3y2+a4yz+a5z20 (2.2)

    holds for all x,y,zR.

    Proof. From straightforward calculations we obtain

    a1x2+a2xz+a3y2+a4yz+a5z2=a1(x+a2z2a1)2+a3(y+a4z2a3)2+(a5a224a1a244a3)z2.

    In view of the above equation, (2.1) leads to (2.2).

    Now we will prove the key estimate for the proof of Theorem 1.2.

    Lemma 2.3. Let (u, v, w) be a solution to (1.1). Under the conditions (1.3)-(1.9) and (1.11), there exist δ1,δ2>0andε>0 such that the nonnegative functions E1 and F1 defined by

    E1(t):=Ω(u1logu)+δ1μ1μ2Ω(v1logv)+δ22Ω(w˜w)2

    and

    F1(t):=Ω(u1)2+Ω(v1)2+Ω(w˜w)2%+Ω|w|2

    satisfy

    ddtE1(t)εF1(t)(t>0). (2.3)

    Proof. Thanks to (1.11), we can choose δ1=βα>0andδ2>0 satisfying

    max{χ1(0)2(1+δ1)4d,μ1χ2(0)2(1+δ1)4μ2d}<δ2<4μ1γδ1α2δ1+β2. (2.4)

    We denote by A1(t), B1(t), C1(t) the functions defined as

    A1(t):=Ω(u1logu),B1(t)=Ω(v1logv),C1(t):=12Ω(w˜w)2,

    and we write as

    E1(t)=A1(t)+δ1μ1μ2B1(t)+δ2C1(t).

    The Taylor formula applied to H(s)=s-log s (s≥0) yields A1(t)=Ω(H(u)H(1)) is a nonnegative function for t > 0 (more detail, see [1, Lemma 3.2]). Similarly, we have that B1(t) is a positive function. By straightforward calculations we infer

    ddtA1(t)=μ1Ω(u1)2Ω|u|2u2+Ωχ1(w)uuw,ddtB1(t)=μ2Ω(v1)2Ω|v|2v2+Ωχ2(w)vvw,ddtC1(t)=Ωhu(u1)(w˜w)+Ωhv(v1)(w˜w)+Ωhw(w˜w)2dΩ|w|2

    with some derivatives hu, hv and hw. Hence we have

    ddtE1(t)=I1(t)+I2(t), (2.5)

    where

    I1(t):=μ1Ω(u1)2δ1μ1Ω(v1)2+δ2Ωhu(u1)(w˜w)+δ2Ωhv(v1)(w˜w)+δ2Ωhw(w˜w)2

    and

    I2(t):=Ω|u|2u2+Ωχ1(w)uuwδ1μ1μ2Ω|v|2v2+δ1μ1μ2Ωχ2(w)vvwdδ2Ω|w|2. (2.6)

    At first, we shall show from Lemma 2.2 that there exists "1 > 0 such that

    I1(t)ε1(Ω(u1)2+Ω(v1)2+Ω(w˜w)2). (2.7)

    To see this, we put

    g1(ε):=μ1ε,g2(ε):=δ1μ1ε,g3(ε):=(δ2hwε)h2u4(μ1ε)δ22h2v4(δ1μ1ε)δ22.

    Since µ1 > 0 and δ1=βα>0, we have g1(0)=µ1 > 0 and g2(0)=δ1μ1>0. In light of (1.5) and the definitions of δ2,α,β>0 (see (1.10) and (2.4)) we obtain

    g3(0)=δ2(hw(h2u4μ1+h2v4δ1μ1)δ2)δ2(γ(α2δ1+β4δ1μ1)δ2)>0.

    Combination of the above inequalities and the continuity of gi for i=1, 2, 3 yield that there exists ε1>0 such that gi(ε1) > 0 hold for i=1, 2, 3. Thanks to Lemma 2.2 with

    a1=μ1ε1,a2=δ2hu,a3=δ1μ1ε1,a4=δ2hv,a5=δ2hwε1,x=u(t)1,y=v(t)1,z=w(t)˜w,

    we obtain (2.7) with ε1>0. Lastly we will prove

    I2(t)0. (2.8)

    Noting that χi<0 (from (1.8)) and then using the Young inequality, we have

    Ωχ1(w)uuwχ1(0)Ω|uw|uχ1(0)2(1+δ1)4dδ2Ω|u|2u2+dδ21+δ1Ω|w|2

    and

    δ1μ1μ2Ωχ2(w)vvwχ2(0)δ1μ1μ2Ω|vw|vχ2(0)2δ1(1+δ1)4dδ2(μ1μ2)2Ω|v|2v2+dδ1δ21+δ1Ω|w|2.

    Plugging these into (2.6) we infer

    I2(t)(1χ1(0)2(1+δ1)4dδ2)Ω|u|2u2δ1μ1μ2(1μ1χ2(0)2(1+δ1)4dμ2δ2)Ω|v|2v2.

    We note from the definition of δ2>0 that

    1χ1(0)2(1+δ1)4dδ2>0,1μ1χ2(0)2(1+δ1)4dμ2δ2>0.

    Thus we have (2.8). Combination of (2.5), (2.7) and (2.8) implies the end of the proof.

    Lemma 2.4. Let (u, v, w) be a solution to (1.1). Under the conditions (1.3)-(1.9) and (1.11), (u, v, w) has the following asymptotic behavior:

    u(t)1L(Ω)0,v(t)1L(Ω)0,w(t)˜wL(Ω)0(t).

    Proof. Firstly the boundedness of u, v, w and a standard parabolic regularity theory ([9]) yield that there exist θ(0,1) and C > 0 such that

    uC2+θ,1+θ2(ˉΩ×[1,t])+vC2+θ,1+θ2(ˉΩ×[1,t])+wC2+θ,1+θ2(ˉΩ×[1,t])C for  all t1.

    Therefore in view of the Gagliardo-Nirenberg inequality

    φL(Ω)cφNN+2W1,(Ω)φ2N+2L(Ω)(φW1,(Ω)), (2.9)

    it is sufficient to show that

    u(t)1L2(Ω)0,v(t)1L2(Ω)0,w(t)˜wL2(Ω)0(t).

    We let

    f1(t):=Ω(u1)2+Ω(v1)2+Ω(w˜w)2.

    We have that f1(t) is a nonnegative function, and thanks to the regularity of u, v, w we can see that f1(t) is uniformly continuous. Moreover, integrating (2.3) over (1, ∞), we infer from the positivity of E1(t) that

    1f1(t)dt1εE1(1)<.

    Therefore we conclude from Lemma 2.1 that f1(t)→0 (t→∞), which means

    Ω(u1)2+Ω(v1)2+Ω(w˜w)20(t).

    This implies the end of the proof.

    Lemma 2.5. Let (u, v, w) be a solution to (1.1). Under the conditions (1.3)-(1.9) and (1.11), there exist C > 0 and λ>0 such that

    u(t)1L(Ω)+v(t)1L(Ω)+w(t)˜wL(Ω)Ceλt(t>0).

    Proof. From the L’Hôpital theorem applied to H(s) :=s-log s we can see

    lims1H(s)H(1)(s1)2=lims1H(s)2=12. (2.10)

    In view of the combination of (2.10) and u1L(Ω)0 from Lemma 2.4 we obtain that there exists t0 > 0 such that

    14Ω(u1)2A1(t)=Ω(H(u)H(1))Ω(u1)2(t>t0). (2.11)

    A similar argument, for the function v, yields that there exists t1 > t0 such that

    14Ω(v1)2B1(t)Ω(v1)2(t>t1). (2.12)

    We infer from (2.11) and the definitions of E1(t), F1(t) that

    E1(t)c6F1(t)

    for all t > t1 with some c6 > 0. Plugging this into (2.3), we have

    ddtE1(t)εF1(t)εc6E1(t)(t>t1),

    which implies that there exist c7 > 0 and >0 such that

    E1(t)c7et(t>t1).

    Thus we obtain from (2.11) and (2.12) that

    Ω(u1)2+Ω(v1)2+Ω(w˜w)2c8E1(t)c7c8et

    for all t > t1 with some c8 > 0. From the Gagliardo-Nirenberg inequality (2.9) with the regularity of u, v, w, we achieve that there exist C > 0 and λ>0 such that

    u(t)1L(Ω)+v(t)1L(Ω)+w(t)˜wL(Ω)Ceλt(t>0).

    This completes the proof of Lemma 2.5.

    Proof of Theorem 1.2. Theorem 1.2 follows directly from Lemma 2.5.


    Acknowledgments

    The authors would like to thank the referee for valuable comments improving the paper.


    [1] Carthew RW, Rubin GM (1990) Seven in absentia, a gene required for specification of R7 cell fate in the Drosophila eye. Cell 63: 561-577. doi: 10.1016/0092-8674(90)90452-K
    [2] Della NG, Senior PV, Bowtell DL (1993) Isolation and characterization of murine homologues of the Drosophila seven in absentia gene (Sina). Development 117: 1333-1343.
    [3] Holloway AJ, Della NG, Fletcher CF, et al. (1997) Chromosomal mapping of five highly conserved murine homologues of the Drosophila RING finger gene seven-in-absentia. Genomics 41: 160-168. doi: 10.1006/geno.1997.4642
    [4] House CM, Hancock NC, Moller A, et al. (2006) Elucidation of the substrate binding site of Siah ubiquitin ligase. Structure 14: 695-701. doi: 10.1016/j.str.2005.12.013
    [5] House CM, Frew IJ, Huang HL, et al. (2003) A binding motif for Siah ubiquitin ligase. Proc Natl Acad Sci USA 100: 3101-3106. doi: 10.1073/pnas.0534783100
    [6] Khurana A, Nakayama K, Williams S, et al. (2006) Regulation of the ring finger E3 ligase Siah2 by p38 MAPK. J Biol Chem 281: 35316-35326. doi: 10.1074/jbc.M606568200
    [7] Scortegagna M, Subtil T, Qi J, et al. (2011) USP13 enzyme regulates Siah2 ligase stability and activity via noncatalytic ubiquitin-binding domains. J Biol Chem 286: 27333-27341. doi: 10.1074/jbc.M111.218214
    [8] Matsuzawa SI, Reed JC (2001) Siah-1, SIP, and Ebi Collaborate in a Novel Pathway for b-Catenin Degradation Linked to p53 Responses. Mol Cell 7: 915-926. doi: 10.1016/S1097-2765(01)00242-8
    [9] Winter M, Sombroek D, Dauth I, et al. (2008) Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR. Nat Cell Biol 10: 812-824. doi: 10.1038/ncb1743
    [10] Zundel W, Schindler C, Haas-Kogan D, et al. (2000) Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 14: 391-396.
    [11] Carthew RW, Neufeld TP, Rubin GM (1994) Identification of genes that interact with the sina gene in Drosophila eye development. Proc Natl Acad Sci USA 91: 11689-11693. doi: 10.1073/pnas.91.24.11689
    [12] Tang AH, Neufeld TP, Kwan E, et al. (1997) PHYL acts to down-regulate TTK88, a transcriptional repressor of neuronal cell fates, by a SINA-dependent mechanism. Cell 90: 459-467. doi: 10.1016/S0092-8674(00)80506-1
    [13] Bogdan S, Senkel S, Esser F, et al. (2001) Misexpression of Xsiah-2 induces a small eye phenotype in Xenopus. Mech Dev 103: 61-69.
    [14] Zhang J, Guenther MG, Carthew RW, et al. (1998) Proteasomal regulation of nuclear receptor corepressor-mediated repression. Genes Dev 12: 1775-1780. doi: 10.1101/gad.12.12.1775
    [15] D'Orazi G, Cecchinelli B, Bruno T, et al. (2002) Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol 4: 11-19. doi: 10.1038/ncb714
    [16] Johnsen SA, Subramaniam M, Monroe DG, et al. (2002) Modulation of transforming growth factor beta (TGFbeta)/Smad transcriptional responses through targeted degradation of TGFbeta-inducible early gene-1 by human seven in absentia homologue. J Biol Chem 277: 30754-30759. doi: 10.1074/jbc.M204812200
    [17] Hu G, Fearon ER (1999) Siah-1 N-terminal RING domain is required for proteolysis function, and C-terminal sequences regulate oligomerization and binding to target proteins. Mol Cell Biol 1: 19724-19732.
    [18] Maxwell PH, Ratciffe PJ (2002) Oxygen sensors and angiogenesis. Semin Cell Dev Biol 13: 29-37. doi: 10.1006/scdb.2001.0287
    [19] McNeill LA, Hewitson KS, Gleadle JM (2002) The use of dioxygen by HIF prolyl hydroxylase (PHD1). Bioorg Med Chem Lett 12: 1547-1550. doi: 10.1016/S0960-894X(02)00219-6
    [20] Qi J, Nakayama K, Gaitonde S, et al. (2008) Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors. Proc Natl Acad Sci USA 105: 16713-16718. doi: 10.1073/pnas.0804063105
    [21] Baba K, Morimoto H, Imaoka S (2013) Seven in absentia homolog 2 (Siah2) protein is a regulator of NF-E2-related factor 2 (Nrf2). J Biol Chem 288: 18393-18405. doi: 10.1074/jbc.M112.438762
    [22] Sajja RK, Green KN, Cucullo L (2015) Altered Nrf2 signaling mediates hypoglycemia-induced blood-brain barrier endothelial dysfunction in vitro. PLos One 10: e0122358. doi: 10.1371/journal.pone.0122358
    [23] Itoh K, Wakabayashi N, Katoh Y, et al. (1999) Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13: 76-86. doi: 10.1101/gad.13.1.76
    [24] Kim H, Scimia MC, Wilkinson D (2011) Fine-tuning of Drp1/Fis1 availability by AKAP121/Siah2 regulates mitochondrial adaptation to hypoxia. Mol Cell 44: 532-544 doi: 10.1016/j.molcel.2011.08.045
    [25] Li Q, Wang P, Ye K, et al. (2015) Central role of SIAH inhibition in DCC-dependent cardioprotection provoked by netrin-1/NO. Proc Natl Acad USA 112: 899-904. doi: 10.1073/pnas.1420695112
    [26] Schmidt RL, Park CH, Ahmed AU, et al. (2007) Inhibition of RAS-mediated transformation and tumorigenesis by targeting the downstream E3 ubiquitin ligase seven in absentia homologue. Cancer Res 67: 11798-11810. doi: 10.1158/0008-5472.CAN-06-4471
    [27] Kim CJ, Cho YG, Park CH, et al. (2004) Inactivating mutations of the Siah-1 gene in gastric cancer. Oncogene 23: 8591-8596. doi: 10.1038/sj.onc.1208113
    [28] Ahmed AU, Sxhmidt RL, Park CH, et al. (2008) Effect of disrupting seven-in-absentia homolog 2 function on lung cancer cell growth. J Natl Cancer Inst 100: 1606-29. doi: 10.1093/jnci/djn365
    [29] Wong CS, Sceneay J, House CM, et al. (2012) Vascular normalization by loss of Siah2 results an increased chemotherapeutic efficacy. Cancer Res 72: 1694-1704. doi: 10.1158/0008-5472.CAN-11-3310
    [30] Shah M, Stebbins JL, Dewing A, et al. (2009) Inhibition of Siah2 ubiquitin ligase by vitamin K3 (menadione) attenuates hypoxia and MAPK signaling and blocks melanoma tumorigenesis. Pigment Cell Melanoma Res 22: 799-808. doi: 10.1111/j.1755-148X.2009.00628.x
    [31] Qi J, Nakayama K, Cardiff RD, et al. (2010) Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors. Cancer Cell 18: 23-38. doi: 10.1016/j.ccr.2010.05.024
    [32] Yoshibayashi H, Okabe H, Satoh S, et al. (2007) SIAH1 causes growth arrst and apoptosis in hepatoma cells through beta-catenin degradation-dependent and –independent mechanisms. Oncol Rep 17: 549-556.
    [33] Roperch J, Lethrone F, Prieur S, et al. (1999) SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and trafficking: identification of common effectors with p53 and p21(Waf1). Proc Natl Acad USA 96: 8070-8073. doi: 10.1073/pnas.96.14.8070
    [34] Malz M, Aulmann A, Samarin J, et al. (2012) Nuclear accumulation of seven in absentia homologue-2 supports motility and proliferation of liver cancer cells. Int J Cancer 131: 2016-2026. doi: 10.1002/ijc.27473
    [35] Wong CS, Moller A (2013) Siah: a promising anticancer target. Cancer Res 73: 2400-2406. doi: 10.1158/0008-5472.CAN-12-4348
    [36] DeBruyne JP, Baggs JE, Sato TK (2015) Ubiquitin ligase Siah2 regulates RevErba degradation and the mammalian circadian clock. Proc Natl Acad Sci USA 112: 12420-12425. doi: 10.1073/pnas.1501204112
    [37] Adam MG, Matt S, Christian S (2015) SIAH ubiquitin ligases regulate breast cancer cell migration and invasion independent of the oxygen status. Cell Cycle 14: 3734-3747. doi: 10.1080/15384101.2015.1104441
    [38] Frasor J, Danes JM, Funk CC, et al. (2005) Estrogen down-regulation of the corepressor N-CoR: mechanism and implications for estrogen derepression of N-CoR-regulated genes. Proc Natl Acad Sci USA 102: 13153-13157. doi: 10.1073/pnas.0502782102
  • This article has been cited by:

    1. Wisdom S. Avusuglo, Nicola Bragazzi, Ali Asgary, James Orbinski, Jianhong Wu, Jude Dzevela Kong, Leveraging an epidemic–economic mathematical model to assess human responses to COVID-19 policies and disease progression, 2023, 13, 2045-2322, 10.1038/s41598-023-39723-0
  • Reader Comments
  • © 2017 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(5826) PDF downloads(939) Cited by(1)

Article outline

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog